19 June 2013
Keywords: FDA, Merck & Co, Dulera, Asthma, Chagas disease, Phase II trial, Noxafil, Posaconazole
Article | 25 June 2010
US drug giant Merck & Co had two pieces of good news yesterday; it received US regulatory clearance for a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 June 2010
18 June 2013
© 2013 thepharmaletter.com